Clensia
Clensia is a medicine authorised by Swissmedic under authorisation number 67326. The authorisation holder is Alfasigma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 October 2019 and the authorisation is valid without a time limit. ATC code A06AD65 places the medicine in the group Drugs for constipation.
| Authorisation number | 67326 |
|---|---|
| Name | Clensia |
| Full name | Clensia, Pulver zum Einnehmen als Lösung |
| Authorisation holder | Alfasigma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A06AD65 |
| First authorisation | 03 October 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Clensia, Pulver zum Einnehmen als Lösung | B | 03 October 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 8 | Sachet(s) | A06AD65 | 04.08.11 | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Clensia authorised in Switzerland?
Yes. Clensia is authorised by Swissmedic under authorisation number 67326, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Clensia have?
Clensia is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Clensia?
The authorisation holder is Alfasigma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.